Abstract: SA-PO585
IL-17 Signaling in CD4+ T Cells Controls TH17 Immune Response
Session Information
- Glomerular Diseases: Immunology, Inflammation - II
November 09, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Glomerular Diseases
- 1202 Glomerular Diseases: Immunology and Inflammation
Authors
- Schmidt, Tilman, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Lübbe, Jonas, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Riedel, Jan-Hendrik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Kilian, Christoph, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Krebs, Christian F., University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Paust, Hans-Joachim, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Panzer, Ulf, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Background
The IL-17/IL-17 receptor system plays a crucial role in autoimmune and chronic inflammatory diseases. The biological effects on residential cells are mediated through a heterodimeric receptor complex consisting of IL-17RA and a ligand specific IL-17 receptor subunit (IL-17RB - IL-17RE). However, the expression and function of IL-17 receptors on hematopoietic cells as CD4+ T cells have not been elucidated.
Methods
Crescentic GN (NTN), Psoriasis and C. rodentium colitis were induced in IL-17RA-/-, IL-17RC-/- and in IL-17A, IFNγ and Foxp3 triple-reporter mice for in vivo cell sorting of CD4+ T cell subsets. Single cell RNAseq of CD4+ T cells from the nephritic kidney was performed using the 10X single cell system. pLIVE-plasmid was used to induce IL-17A overexpression in vivo. Moreover, we generated TH17 cell specific IL-17RA gene-deficient mice to study the role of IL-17 signaling in TH17 cells in the NTN model.
Results
Induction of inflammation in the kidney, skin and intestine in IL-17RA-/- mice resulted in an aggravated TH17 cell immune response. Transfer of IL-17RA-/- bone marrow cells in irradiated WT mice indicated IL-17 signaling on hematopoietic cells. CD4+ IL-17 producing WT cells from the inflamed kidney, analyzed with single cell RNAseq, demonstrated a highly activated IL-17 signaling score. mRNA expression analysis of FACS-sorted T cells revealed predominant expression of IL-17RC and IL-17RE by IL-17A+ TH17 cells, whereas IL-17RA is ubiquitously expressed by all CD4+ T cell subsets, demonstrating a T cell specific expression pattern of IL-17 receptors. Systemic overexpression of IL-17A showed a reduction of CD4+ IL-17A+ cells in the kidneys of nephritic mice. Moreover, competitive adoptive transfer experiments of wildtype and IL-17RA-/- or IL-17RC-/- CD4+ T cells into nephritic Rag1-/- mice showed that IL-17 signaling on CD4+ T cells is critically for the control of the pathogenic TH17 response. Mice specifically lacking the IL-17RA receptor in IL-17A+ cells also present an enhanced TH17 cell immune response.
Conclusion
Our findings indicate intrinsic IL-17RA/RC signaling on CD4+ T cells, which regulates the TH17 cell immune response. This novel mechanism might lead to more efficient therapeutic options in targeting IL-17 signaling pathways.